Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with REGN: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
REGN
Regeneron Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
REGN
Regeneron Pharmaceuticals, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
LLY
ELI Lilly & Co
Change
1,363.79
▼
−0.07%
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
REGN
Regeneron Pharmaceuticals, Inc.
Change
909.94
▲
+0.78%
Regular session
Nov 6 '26
Mkt cap
$93.4B
Revenue
$5.1B
Q3 FY26
Revenue
$14.3B
FY25
vs
Compare
Regular session
Nov 6 '26
LLY
ELI Lilly & Co
vs
REGN
Regeneron Pharmaceuticals, Inc.
1,363.79
▼
−0.07%
Price
909.94
▲
+0.78%
$1.2T
Mkt cap
$93.4B
Q3 FY26
$24.4B
Revenue
$5.1B
Q3 FY26
FY25
$65.2B
Revenue
$14.3B
FY25
Change
Change
LLY
1,363.79
▼
−0.07%
vs
REGN
909.94
▲
+0.78%
Regular session
Nov 6 '26
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
LLY, solid
REGN, dashed